$MMSI
MERIT MEDICAL SYSTEMS INC

2020 Q1 Form 10-Q Financial Statement

#000085698220000022 Filed on May 11, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $243.5M $238.3M
YoY Change 2.17% 17.39%
Cost Of Revenue $139.7M $133.7M
YoY Change 4.51% 16.29%
Gross Profit $103.8M $104.6M
YoY Change -0.81% 18.83%
Gross Profit Margin 42.62% 43.9%
Selling, General & Admin $78.81M $78.27M
YoY Change 0.69% 20.58%
% of Gross Profit 75.93% 74.8%
Research & Development $14.87M $16.04M
YoY Change -7.3% 12.02%
% of Gross Profit 14.33% 15.33%
Depreciation & Amortization $23.32M $22.35M
YoY Change 4.35% 46.22%
% of Gross Profit 22.47% 21.36%
Operating Expenses $102.4M $95.11M
YoY Change 7.68% 19.98%
Operating Profit $1.362M $9.523M
YoY Change -85.7% 8.45%
Interest Expense $3.144M $2.764M
YoY Change 13.75% 15.26%
% of Operating Profit 230.84% 29.02%
Other Income/Expense, Net -$3.354M -$2.677M
YoY Change 25.29% 10.53%
Pretax Income -$1.992M $6.846M
YoY Change -129.1% 7.66%
Income Tax $1.162M $651.0K
% Of Pretax Income 9.51%
Net Earnings -$3.154M $6.195M
YoY Change -150.91% 17.57%
Net Earnings / Revenue -1.3% 2.6%
Basic Earnings Per Share -$0.06 $0.11
Diluted Earnings Per Share -$0.06 $0.11
COMMON SHARES
Basic Shares Outstanding 55.25M 54.92M
Diluted Shares Outstanding 55.25M 56.49M

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $50.10M $49.50M
YoY Change 1.21% 44.74%
Cash & Equivalents $50.08M $49.52M
Short-Term Investments
Other Short-Term Assets $19.80M $14.80M
YoY Change 33.78% 8.03%
Inventory $227.8M $198.9M
Prepaid Expenses
Receivables $150.1M $146.5M
Other Receivables $14.80M $12.00M
Total Short-Term Assets $462.5M $421.8M
YoY Change 9.66% 22.69%
LONG-TERM ASSETS
Property, Plant & Equipment $384.9M $340.8M
YoY Change 12.94% 12.19%
Goodwill $352.2M $335.0M
YoY Change 5.16% 37.2%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $36.57M $60.05M
YoY Change -39.1% 61.12%
Total Long-Term Assets $1.287B $1.268B
YoY Change 1.48% 41.61%
TOTAL ASSETS
Total Short-Term Assets $462.5M $421.8M
Total Long-Term Assets $1.287B $1.268B
Total Assets $1.749B $1.690B
YoY Change 3.52% 36.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $56.00M $51.70M
YoY Change 8.32% 18.31%
Accrued Expenses $87.10M $91.31M
YoY Change -4.62% 58.71%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $7.000M
YoY Change -100.0% 0.0%
Long-Term Debt Due $7.500M $22.00M
YoY Change -65.91% 6.11%
Total Short-Term Liabilities $165.3M $178.5M
YoY Change -7.38% 43.46%
LONG-TERM LIABILITIES
Long-Term Debt $438.1M $362.2M
YoY Change 20.97% -0.99%
Other Long-Term Liabilities $70.89M $62.36M
YoY Change 13.68% 289.07%
Total Long-Term Liabilities $509.0M $424.5M
YoY Change 19.9% 11.19%
TOTAL LIABILITIES
Total Short-Term Liabilities $165.3M $178.5M
Total Long-Term Liabilities $509.0M $424.5M
Total Liabilities $809.5M $749.7M
YoY Change 7.98% 36.13%
SHAREHOLDERS EQUITY
Retained Earnings $364.5M $369.7M
YoY Change -1.41% 13.17%
Common Stock $590.1M $574.9M
YoY Change 2.63% 61.4%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $939.8M $940.1M
YoY Change
Total Liabilities & Shareholders Equity $1.749B $1.690B
YoY Change 3.52% 36.36%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income -$3.154M $6.195M
YoY Change -150.91% 17.57%
Depreciation, Depletion And Amortization $23.32M $22.35M
YoY Change 4.35% 46.22%
Cash From Operating Activities $28.86M $13.51M
YoY Change 113.73% 70.2%
INVESTING ACTIVITIES
Capital Expenditures $13.95M $18.26M
YoY Change -23.58% 12.41%
Acquisitions $1.942M
YoY Change -98.06%
Other Investing Activities $300.0K -$1.900M
YoY Change -115.79% -98.1%
Cash From Investing Activities -$14.76M -$21.05M
YoY Change -29.86% -82.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.261M $1.733M
YoY Change -27.24% 14.69%
Debt Paid & Issued, Net $24.54M $54.12M
YoY Change -54.66% -63.67%
Cash From Financing Activities -6.234M -9.821M
YoY Change -36.52% -108.97%
NET CHANGE
Cash From Operating Activities 28.86M 13.51M
Cash From Investing Activities -14.76M -21.05M
Cash From Financing Activities -6.234M -9.821M
Net Change In Cash 5.760M -17.84M
YoY Change -132.29% -1072.04%
FREE CASH FLOW
Cash From Operating Activities $28.86M $13.51M
Capital Expenditures $13.95M $18.26M
Free Cash Flow $14.91M -$4.750M
YoY Change -413.98% -42.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000856982
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
MERIT MEDICAL SYSTEMS INC
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55338000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55213000
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Entity File Number
EntityFileNumber
0-18592
CY2020Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
UT
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0447695
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1600 West Merit Parkway
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
South Jordan
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84095
CY2020Q1 dei City Area Code
CityAreaCode
801
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
253-1600
CY2020Q1 dei Security12b Title
Security12bTitle
Common Stock, no par
CY2020Q1 dei Trading Symbol
TradingSymbol
MMSI
CY2020Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
55384036
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50080000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
44320000
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4124000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3108000
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
150050000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
155365000
CY2020Q1 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
9246000
CY2019Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
10016000
CY2020Q1 us-gaap Inventory Net
InventoryNet
227776000
CY2019Q4 us-gaap Inventory Net
InventoryNet
225698000
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
16284000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12497000
CY2020Q1 us-gaap Prepaid Taxes
PrepaidTaxes
3486000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
78808000
CY2019Q4 us-gaap Prepaid Taxes
PrepaidTaxes
3491000
CY2020Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
5586000
CY2019Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
3151000
CY2020Q1 us-gaap Assets Current
AssetsCurrent
462508000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
454538000
CY2020Q1 us-gaap Land
Land
27695000
CY2019Q4 us-gaap Land
Land
27554000
CY2020Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
153896000
CY2019Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
153863000
CY2020Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
247878000
CY2019Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
244368000
CY2020Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
58955000
CY2019Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
57623000
CY2020Q1 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
43950000
CY2019Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
43311000
CY2020Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
91802000
CY2019Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
83685000
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
624176000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
610404000
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
239316000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
231619000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
384860000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
378785000
CY2020Q1 us-gaap Goodwill
Goodwill
352242000
CY2019Q4 us-gaap Goodwill
Goodwill
353193000
CY2020Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3716000
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3788000
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
79133000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
80244000
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
36569000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
41461000
CY2020Q1 mmsi Intangible Assets Net Goodwill And Other Assets Noncurrent
IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent
901904000
CY2019Q4 mmsi Intangible Assets Net Goodwill And Other Assets Noncurrent
IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent
923998000
CY2020Q1 us-gaap Assets
Assets
1749272000
CY2019Q4 us-gaap Assets
Assets
1757321000
CY2020Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
56012000
CY2019Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
54623000
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
87095000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
105184000
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
7500000
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7500000
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11670000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11550000
CY2020Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3014000
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2799000
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
165291000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
181656000
CY2020Q1 mmsi Business Combination Contingent Consideration Arrangements Contingent Consideration Benefit
BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit
-4897000
CY2020Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
14066000
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
438137000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
431984000
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
45027000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
45236000
CY2020Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
347000
CY2019Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
347000
CY2020Q1 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
1990000
CY2019Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
1990000
CY2019Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
14855000
CY2020Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2088000
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2122000
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
71642000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
72714000
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
70886000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
56473000
CY2020Q1 us-gaap Liabilities
Liabilities
809474000
CY2019Q4 us-gaap Liabilities
Liabilities
807377000
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55338000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55213000
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
590065000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
587017000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
364492000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
368221000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14759000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5294000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
939798000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
949944000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1749272000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1757321000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
243525000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
238349000
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
139741000
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
133713000
CY2020Q1 us-gaap Gross Profit
GrossProfit
103784000
CY2019Q1 us-gaap Gross Profit
GrossProfit
104636000
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
78270000
CY2020Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
14872000
CY2019Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
16043000
CY2020Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
3845000
CY2019Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2019Q1 mmsi Business Combination Contingent Consideration Arrangements Contingent Consideration Benefit
BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit
-775000
CY2019Q1 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
25000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
102422000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
95113000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1362000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
9523000
CY2020Q1 us-gaap Investment Income Net
InvestmentIncomeNet
79000
CY2019Q1 us-gaap Investment Income Net
InvestmentIncomeNet
357000
CY2020Q1 us-gaap Interest Expense
InterestExpense
3144000
CY2019Q1 us-gaap Interest Expense
InterestExpense
2764000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-289000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-270000
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3354000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2677000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1992000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
6846000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1162000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
651000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-3154000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
6195000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55246000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54917000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55246000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56490000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-3154000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
6195000
CY2020Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
-7182000
CY2019Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
-2577000
CY2020Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
-1849000
CY2019Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
-663000
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-4125000
CY2019Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-615000
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
7000
CY2019Q1 us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
-14000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-9465000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2515000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-12619000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
3680000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
949944000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-3154000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-9465000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2641000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2369000
CY2020Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
371000
CY2020Q1 mmsi Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2945000
CY2020Q1 mmsi Stock Surrendered During Period Value Payroll Tax Liabilities Stock Options Exercised
StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised
866000
CY2020Q1 mmsi Stock Surrendered During Period Value Stock Options Exercised
StockSurrenderedDuringPeriodValueStockOptionsExercised
1467000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
939798000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
932775000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
6195000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2515000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1766000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1365000
CY2019Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
432000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
940111000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-3154000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
6195000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23320000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
22348000
CY2020Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-37000
CY2019Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-288000
CY2020Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
3925000
CY2019Q1 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
25000
CY2020Q1 mmsi Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
3134000
CY2019Q1 mmsi Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
2964000
CY2020Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
4897000
CY2019Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
775000
CY2020Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
35000
CY2019Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
35000
CY2020Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
151000
CY2019Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
201000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2777000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1766000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3445000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11557000
CY2020Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-613000
CY2019Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-1090000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4983000
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1340000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3126000
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-19000
CY2019Q1 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
53000
CY2020Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
2475000
CY2019Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
442000
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
577000
CY2019Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2092000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
4340000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-878000
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1621000
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2976000
CY2020Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
2109000
CY2019Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-879000
CY2020Q1 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-789000
CY2019Q1 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
1261000
CY2019Q1 mmsi Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-3054000
CY2020Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-179000
CY2019Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-121000
CY2020Q1 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
32018000
CY2019Q1 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
7310000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
28864000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
13505000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13950000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18255000
CY2020Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1062000
CY2019Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
853000
CY2019Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
3000
CY2020Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
250000
CY2019Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1942000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14762000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21047000
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1261000
CY2019Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1733000
CY2020Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
30665000
CY2019Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
43119000
CY2020Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
24540000
CY2019Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
54119000
CY2020Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
12754000
CY2019Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
554000
CY2020Q1 mmsi Payments Related To Tax Withholding For Exchange Of Common Stock
PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock
866000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6234000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-9821000
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2108000
CY2019Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-474000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5760000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-17837000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
44320000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
67359000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50080000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49522000
CY2020Q1 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
392000
CY2019Q1 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
241000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
3198000
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
2721000
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1637000
CY2019Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1934000
CY2020Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5383000
CY2019Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4588000
CY2020Q1 mmsi Fair Value Of Equity Investment In Exchange For Settlement Of Note Receivable
FairValueOfEquityInvestmentInExchangeForSettlementOfNoteReceivable
899000
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2800000
CY2019Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1162000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
238349000
CY2019Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
775000
CY2020Q1 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<p style="font-family:'Times New Roman';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">2.   Recently Issued Financial Accounting Standards.</p><p style="font-family:'Times New Roman';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><i style="font-weight:normal;">Recently Adopted</i></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In August 2018, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2018-15, <i style="font-style:italic;">Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract, </i>which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). ASU 2018-15 became effective for us on January 1, 2020. The adoption of this standard did not have a material impact on our consolidated financial statements.</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In August 2018, the FASB issued ASU 2018-13, <i style="font-style:italic;">Fair Value Measurement (Topic 820)</i>, which removes, modifies and adds various disclosure requirements related to fair value disclosures. ASU 2018-13 became effective for us beginning on January 1, 2020. We modified our disclosures beginning in the three-month period ended March 31, 2020 to conform with this guidance (see Note 14). </p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In June 2016, the FASB issued ASU 2016-13, <i style="font-style:italic;">Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</i>, which replaced the incurred loss impairment methodology for financial assets with a methodology that reflects expected credit losses. The new credit loss model must be applied to loans, accounts receivable, and other financial assets. ASU 2016-13 became effective for us beginning on January 1, 2020. We adopted this standard using a modified retrospective approach with a cumulative-effect adjustment to retained earnings of $575,000 as of the beginning of 2020. See Note 14 for additional disclosures related to our allowance for current expected credit losses. The adoption of this guidance did not have a material impact on our statements of operations or cash flows. </p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">We currently believe that all other issued and not yet effective accounting standards are not relevant to our financial statements.</p>
CY2020Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
243525000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56490000
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2020Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
126495000
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
134467000
CY2020Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
24592000
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
17602000
CY2020Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
76689000
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
73629000
CY2020Q1 us-gaap Inventory Net
InventoryNet
227776000
CY2019Q4 us-gaap Inventory Net
InventoryNet
225698000
CY2019Q4 us-gaap Goodwill
Goodwill
353193000
CY2020Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-951000
CY2020Q1 us-gaap Goodwill
Goodwill
352242000
CY2020Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
8300000
CY2019Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
8300000
CY2019Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15000000.0
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14800000
CY2019Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2020Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
44365000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
51932000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
50625000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
49417000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
46465000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1200000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
651000
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.583
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.095
CY2020Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
488000
CY2019Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
516000
CY2020Q1 us-gaap Long Term Debt
LongTermDebt
445637000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
439484000
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
7500000
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7500000
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
438137000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
431984000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
5625000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
7500000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
8438000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
11250000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
413312000
CY2020Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
446125000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-3154000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
6195000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55246000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54917000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55246000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54917000
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1573000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55246000
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4340000
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
976000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2777000
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1766000
CY2020Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
243525000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
238349000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1362000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
9523000
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3354000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2677000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1162000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
651000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-3154000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
6195000
CY2020Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
14500000
CY2019Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
17100000
CY2020Q1 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
2100000
CY2019Q4 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
2700000
CY2020Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
670000
CY2020Q1 us-gaap Allowance For Loan And Lease Losses Adjustments Net
AllowanceForLoanAndLeaseLossesAdjustmentsNet
575000
CY2020Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
95000
CY2020Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
670000

Files In Submission

Name View Source Status
0000856982-20-000022-index-headers.html Edgar Link pending
0000856982-20-000022-index.html Edgar Link pending
0000856982-20-000022.txt Edgar Link pending
0000856982-20-000022-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mmsi-20200331.xsd Edgar Link pending
mmsi-20200331ex311235151.htm Edgar Link pending
mmsi-20200331ex312bb360d.htm Edgar Link pending
mmsi-20200331ex321e0fbb8.htm Edgar Link pending
mmsi-20200331ex322f69736.htm Edgar Link pending
mmsi-20200331x10q.htm Edgar Link pending
mmsi-20200331x10q001.jpg Edgar Link pending
mmsi-20200331x10q_htm.xml Edgar Link completed
mmsi-20200331_cal.xml Edgar Link unprocessable
mmsi-20200331_def.xml Edgar Link unprocessable
mmsi-20200331_lab.xml Edgar Link unprocessable
mmsi-20200331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending